Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Risk factors for venous thrombotic disease.

Rosendaal FR.

Thromb Haemost. 1999 Aug;82(2):610-9. Review. No abstract available.

PMID:
10605758
2.

[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].

Tóth O, Dávid M, Habon T, Nagy A, Keszthelyi Z, Kovács N, Losonczy H.

Orv Hetil. 2005 Oct 9;146(41):2121-5. Review. Hungarian.

PMID:
16304806
3.

Genetic approach to thrombophilia.

Bertina RM.

Thromb Haemost. 2001 Jul;86(1):92-103. Review.

PMID:
11487047
4.

Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.

Marie I, Maurey G, Hervé F, Hellot MF, Levesque H.

Br J Dermatol. 2006 Oct;155(4):714-21. Review.

PMID:
16965420
5.

[Age, an independent risk factor for thrombosis. Epidemiologic data].

Mahé I, Caulin C, Bergmann JF.

Presse Med. 2005 Jul 2;34(12):878-86. Review. French.

PMID:
16097213
6.

Elevated factor VIII levels and the risk of thrombosis.

Kamphuisen PW, Eikenboom JC, Bertina RM.

Arterioscler Thromb Vasc Biol. 2001 May;21(5):731-8. Review. No abstract available.

7.

Thrombosis and bleeding: when opposites are not so far apart.

Franchini M, Veneri D.

Clin Lab. 2005;51(3-4):173-82. Review.

PMID:
15819173
8.

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.

Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G.

Thromb Res. 2008;122(6):736-42. Epub 2007 Oct 22. Review.

PMID:
17949795
9.

Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.

Kessler CM.

Semin Hematol. 2004 Apr;41(2 Suppl 3):10-4. Review.

PMID:
15190517
10.

Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.

Petrides PE, Siegel F.

Blood Cells Mol Dis. 2006 May-Jun;36(3):379-84. Epub 2006 Mar 24. Review.

PMID:
16563815
11.

[Genetic predisposition to arterial and venous thrombosis].

Cadroy Y, Boneu B.

Arch Mal Coeur Vaiss. 2001 Nov;94(11 Suppl):1220-4. Review. French.

PMID:
11794962
12.

Venous and arterial thrombosis: epidemiology and risk factors at various ages.

Lowe GD.

Maturitas. 2004 Apr 15;47(4):259-63. Review.

PMID:
15063477
13.

Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature.

Girolami A, Tezza F, Scapin M, Vettore S, Casonato A.

J Thromb Thrombolysis. 2006 Apr;21(2):175-8. Review.

PMID:
16622614
14.

Estrogen therapy and thrombotic risk.

Miller VM, Jayachandran M, Heit JA, Owen WG.

Pharmacol Ther. 2006 Sep;111(3):792-807. Epub 2006 Feb 10. Review.

PMID:
16473411
15.

The risk of thrombosis in essential thrombocythemia and polycythemia vera.

Pearson TC.

Semin Oncol. 2002 Jun;29(3 Suppl 10):16-21. Review.

PMID:
12096353
16.

Haemostatic genetic risk factors in arterial thrombosis.

Simmonds RE, Hermida J, Rezende SM, Lane DA.

Thromb Haemost. 2001 Jul;86(1):374-85. Review.

PMID:
11487027
17.

Genetic risk factors of venous thrombosis.

Franco RF, Reitsma PH.

Hum Genet. 2001 Oct;109(4):369-84. Review.

PMID:
11702218
18.

Racial disparities in risk factors for thrombosis.

Itakura H.

Curr Opin Hematol. 2005 Sep;12(5):364-9. Review.

PMID:
16093781
19.

Common risk factors for both arterial and venous thrombosis.

Lowe GD.

Br J Haematol. 2008 Mar;140(5):488-95. doi: 10.1111/j.1365-2141.2007.06973.x. Review.

PMID:
18275426
20.

Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies.

Reiner AP, Siscovick DS, Rosendaal FR.

Rev Clin Exp Hematol. 2001 Sep;5(3):262-87; discussion 311-2. Review.

PMID:
11703818
Items per page

Supplemental Content

Write to the Help Desk